IBM CEO Predicts Quantum’s Trillion-Dollar Era by 2029
IBM CEO Arvind Krishna has set a clear timeline: measurable commercial impact from quantum computing by 2029, and the potential to create a trillion dollars or more in value by the late 2030s. That outlook ties executive vision to product milestones and a roadmap from prototype systems toward industry-grade quantum services.
Early Wins and Practical Impact
Unlocking New Discoveries
Recent research from IBM in collaboration with Algorithmiq and other partners has moved beyond theory toward demonstrations of quantum advantage for targeted problems. Early use cases focus on materials science and molecular simulation where quantum processors can explore chemical space more efficiently than classical methods. Practical outcomes include faster identification of battery materials with higher energy density and simulation workflows that accelerate candidate drug discovery. These are not universal solutions yet, but they show where near-term commercial value can emerge.
Addressing Hurdles and Security
IBM’s Strategic Investments
IBM is backing its predictions with concrete investments: AI and quantum hubs to foster industry partnerships, expanded cloud access to quantum processors, and significant federal funding for research and infrastructure. Those moves aim to scale talent, tooling, and customer pilots so that commercial use cases mature before 2029.
The Quantum Encryption Challenge
Parallel to commercial promise is a security timeline. Public research, including work cited by Google, suggests future quantum systems may threaten current public-key encryption within a decade. That projection has accelerated adoption of post-quantum cryptography standards and migration planning across governments and enterprises. Organizations should inventory cryptographic assets, adopt post-quantum algorithms as standards evolve, and plan phased upgrades to protect long-lived secrets.
Bottom line: Krishna’s timeline is ambitious but anchored in demonstrable experiments, targeted industry programs, and growing public investment. Expect targeted commercial wins in materials and pharmaceuticals while security teams rush to implement post-quantum defenses.
